Mereo BioPharma Group plc
- MREO
- NASDAQ
- Biotechnology
- Oncology Therapies
- Rare Disease Drugs
$0.30
Today −0.30%Quote Oct 19, 2026, 08:00 PM UTC
−0.30%over the last month
Max drawdown −24.9%From 1-month high −24.9%3 months −1.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Mereo BioPharma
Mereo BioPharma Group plc, a London-based biopharmaceutical firm established in 2015, specializes in developing and commercializing innovative therapies for oncology and rare conditions. Operating both in the United Kingdom and internationally, the company boasts a diverse product pipeline.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
39
Market value
$241.2M
Quote Oct 19
Floor
$0.30
0.5% below price
Resistance
$0.32
6.0% above price
Price vs analyst targets
8 analysts
Lowest target
$0.50Highest target
$8.00
$0.50Highest target
$8.00
- Price $0.30
- Average target $3.25
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 976% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about MREOPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free